China’s first AI-powered cancer vaccine production line set to launch in Beijing

AI Summary

China has initiated construction of its first AI-assisted personalized cancer vaccine production line in Beijing. The new facility, expected to be completed by October, aims to boost drug research and manufacturing and benefit millions of cancer patients in the country.

China has broken ground on what developers say is the country’s first production line for AI-assisted personalised tumour vaccines, raising hopes for millions of new cancer patients every year – a disease that ranks as the nation’s second-leading cause of death. By October, Beijing-based Likang Life Sciences is expected to complete a new drug research and manufacturing centre in the Beijing Economic and Technological Development Zone, with a total investment of about 110 million yuan (US$16.1...